DRREDDY:NSE
Dr Reddy's Laboratories Ltd
₹ 1,213.30
arrow_upward
+1.36%(+16.30) Siku 1
12 Okt, 10:26:32 GMT +5:30 · INR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya DRREDDY...
Fungua
₹ 1,197.00
Juu
₹ 1,218.90
Chini
₹ 1,196.90
Mtaji wa soko
1.01T
Wastani wa kiasi cha mauzo
1.79M
Kiasi cha mauzo ya hisa
elfu 193.94
Gawio
0.66%
Mgawo wa faida wa kila robo mwaka
₹ 2.00
Tarehe ya kutojumuisha gawio
10 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
31.37
Juu kwa wiki 52
₹ 1,414.90
Chini kwa wiki 52
₹ 1,101.00
EPS
₹ 38.67
Hisa za wawekezaji
166.06M
Idadi ya wafanyakazi
elfu 28
Fungua
₹ 1,197.00
Juu
₹ 1,218.90
Chini
₹ 1,196.90
Mtaji wa soko
1.01T
Wastani wa kiasi cha mauzo
1.79M
Kiasi cha mauzo ya hisa
elfu 193.94
Gawio
0.66%
Mgawo wa faida wa kila robo mwaka
₹ 2.00
Tarehe ya kutojumuisha gawio
10 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
31.37
Juu kwa wiki 52
₹ 1,414.90
Chini kwa wiki 52
₹ 1,101.00
EPS
₹ 38.67
Hisa za wawekezaji
166.06M
Idadi ya wafanyakazi
elfu 28
Hisa zinazohusiana
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
CryptoRank
·
dakika 29 zilizopita
XRP Faces a Major October 12 Catalyst as Evernorth Debuts on Nasdaq
Yahoo Finance
·
saa 1 iliyopita
Dow, S&P 500, Nasdaq Futures Climb After Oil In Focus As Trump Declares ‘Energy Ceasefire’ Between Russia And Ukraine: IREN, WFF, VSTM, CIFR Stocks In Focus
The Crypto Times
·
dakika 50 zilizopita
Crypto Week Ahead: US CPI, Evernorth’s XRPN Nasdaq Debut, US Bank Earnings
Barchart.com
·
saa 7 zilizopita
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Wasifu
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Kuhusu Dr Reddy's Laboratories Ltd
Afisa Mkuu Mtendaji (CEO)Erez Israeli
Wafanyakazielfu 27.5
Lilianzishwa1984
Makao makuuHyderabad, Andhra Pradesh, India
Sekta-
Tovutidrreddys.com